| Status: | Approved |
| Entry Type: | Unknown |
| Molecule Category: | Salt |
| Parent Compound: | OLANZAPINE |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Schizophrenia | Phase 1/Phase 2 | ClinicalTrials |
| Schizophrenia; Weight Gain | Phase 4 | ClinicalTrials |
| Schizophrenia | Phase 3 | ClinicalTrials |
| Schizophrenia | Phase 4 | ClinicalTrials |
| Schizophrenia; Weight Gain | Phase 4 | ClinicalTrials |
| Bipolar Disorder; Disease | Phase 3 | ClinicalTrials |
Related Entries
CONTENTS